Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 3781 AL 3795

Predictors of discontinuation, efficacy, and safety of memantine treatment for Alzheimer's disease: meta-analysis and meta-regression of 18 randomized clinical trials involving 5004 patients

Blanco-Silvente L, Capellà D, Garre-Olmo J, Vilalta-Franch J, Castells X.

BMC Geriatr. 2018 Jul 24;18(1):168. doi: 10.1186/s12877-018-0857-5.

Natural product-based multitargeted ligands for Alzheimer's disease treatment?

Tzvetkov NT, Atanasov AG.

Future Med Chem. 2018 Aug;10(15):1745-1748. doi: 10.4155/fmc-2018-0146. Epub 2018 Jul 25.

Pharmacokinetics, Safety, Tolerability, and Pharmacodynamics of Alicapistat, a Selective Inhibitor of Human Calpains 1 and 2 for the Treatment of Alzheimer Disease: An Overview of Phase 1 Studies

Lon HK, Mendonca N, Goss S, Othman AA, Locke C, Jin Z, Rendenbach-Mueller B.

Clin Pharmacol Drug Dev. 2019 Apr;8(3):290-303. doi: 10.1002/cpdd.598. Epub 2018 Jul 27.

Improvement of Main Cognitive Functions in Patients with Alzheimer's Disease after Treatment with Coconut Oil Enriched Mediterranean Diet: A Pilot Study

de la Rubia Ortí JE, García-Pardo MP, Drehmer E, Sancho Cantus D, Julián Rochina M, Aguilar MA, Hu Yang I.

J Alzheimers Dis. 2018;65(2):577-587. doi: 10.3233/JAD-180184.

A review of clinical treatment considerations of donepezil in severe Alzheimer's disease

Adlimoghaddam A, Neuendorff M, Roy B, Albensi BC.

CNS Neurosci Ther. 2018 Oct;24(10):876-888. doi: 10.1111/cns.13035. Epub 2018 Jul 29.

Trends and disparities in the use of cholinesterase inhibitors to treat Alzheimer's disease dispensed by the Brazilian public health system - 2008 to 2014: a nation-wide analysis

Moraes FS, Souza MLC, Lucchetti G, Lucchetti ALG.

Arq Neuropsiquiatr. 2018 Jul;76(7):444-451. doi: 10.1590/0004-282X20180064.

Management of behavioral and psychological symptoms in people with Alzheimer's disease: an international Delphi consensus

Kales HC, Lyketsos CG, Miller EM, Ballard C.

Int Psychogeriatr. 2019 Jan;31(1):83-90. doi: 10.1017/S1041610218000534. Epub 2018 Aug 2.

Stem cell- and gene-based therapies as potential candidates in Alzheimer's therapy

Hosseini SA, Mohammadi R, Noruzi S, Mohamadi Y, Azizian M, Mousavy SM, Ghasemi F, Hesari A, Sahebkar A, Salarinia R, Aghdam AM, Mirzaei H.

J Cell Biochem. 2018 Nov;119(11):8723-8736. doi: 10.1002/jcb.27202. Epub 2018 Aug 3.

Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human Brain

Hey JA, Kocis P, Hort J, Abushakra S, Power A, Vyhnálek M, Yu JY, Tolar M.

CNS Drugs. 2018 Sep;32(9):849-861. doi: 10.1007/s40263-018-0554-0.

Differential effects of cognition-focused interventions for people with Alzheimer's disease: A meta-analysis

Oltra-Cucarella J, Ferrer-Cascales R, Clare L, Morris SB, Espert R, Tirapu J, Sánchez-SanSegundo M.

Neuropsychology. 2018 Sep;32(6):664-679. doi: 10.1037/neu0000449. Epub 2018 Aug 6.

A Recent Update on the Effects of Omega-3 Fatty Acids in Alzheimer's Disease

Ajith TA.

Curr Clin Pharmacol. 2018;13(4):252-260. doi: 10.2174/1574884713666180807145648.

Gender Differences in Neuropsychiatric Symptoms in Mild to Moderate Alzheimer's Disease Patients Undergoing Switch of Cholinesterase Inhibitors: A Post Hoc Analysis of the EVOLUTION Study

Colombo D, Caltagirone C, Padovani A, Sorbi S, Spalletta G, Simoni L, Ori A, Zagni E.

J Womens Health (Larchmt). 2018 Nov;27(11):1368-1377. doi: 10.1089/jwh.2017.6420. Epub 2018 Sep 8.

Psychosocial interventions for Alzheimer's disease cognitive symptoms: a Bayesian network meta-analysis

Duan Y, Lu L, Chen J, Wu C, Liang J, Zheng Y, Wu J, Rong P, Tang C.

BMC Geriatr. 2018 Aug 7;18(1):175. doi: 10.1186/s12877-018-0864-6.

Cognitive Therapy for Dementia Patients: A Systematic Review

Carrion C, Folkvord F, Anastasiadou D, Aymerich M.

Dement Geriatr Cogn Disord. 2018;46(1-2):1-26. doi: 10.1159/000490851. Epub 2018 Aug 9.

Neural correlates of liraglutide effects in persons at risk for Alzheimer's disease

Watson KT, Wroolie TE, Tong G, Foland-Ross LC, Frangou S, Singh M, McIntyre RS, Roat-Shumway S, Myoraku A, Reiss AL, Rasgon NL.

Behav Brain Res. 2019 Jan 1;356:271-278. doi: 10.1016/j.bbr.2018.08.006. Epub 2018 Aug 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias